Kira M. Schwartz
Secrétaire Général chez VITAE PHARMACEUTICALS INC
Profil
Kira M.
Schwartz is a professional with a career history that includes current and former positions, as well as education.
Currently, Ms. Schwartz works as a Secretary at Vitae Pharmaceuticals LLC.
Previously, Ms. Schwartz worked as a Secretary at Allergan GI Corp.
and Tobira Therapeutics, Inc. Additionally, Ms. Schwartz worked as a General Counsel at Prevail Therapeutics, Inc. Ms. Schwartz received an undergraduate degree from Tufts University and a graduate degree from Yale Law School.
Postes actifs de Kira M. Schwartz
| Sociétés | Poste | Début |
|---|---|---|
| VITAE PHARMACEUTICALS INC | Secrétaire Général | 25/10/2016 |
Anciens postes connus de Kira M. Schwartz
| Sociétés | Poste | Fin |
|---|---|---|
Allergan GI Corp.
 Allergan GI Corp. BiotechnologyHealth Technology Allergan GI Corp. develops peptide therapeutics for the treatment of gastrointestinal disorders. It provides RM-493 a small-peptide melanocortin-4 receptor agonist, for the treatment of obesity and diabetes, and RM-131 a small-peptide ghrelin agonist, for the treatment of diabetic gastro paresis and other gastrointestinal functional disorders. The company was founded by Bart Henderson and Elizabeth Stoner in 2008 and is headquartered in Madison, NJ. | Secrétaire Général | - |
| TOBIRA THERAPEUTICS INC | Secrétaire Général | - |
| PREVAIL THERAPEUTICS INC. | Conseiller Juridique Général | - |
Formation de Kira M. Schwartz
| Yale Law School | Graduate Degree |
| Tufts University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Prevail Therapeutics, Inc.
 Prevail Therapeutics, Inc. BiotechnologyHealth Technology Prevail Therapeutics, Inc. develops therapeutics for neurodegenerative diseases. The firm engages in the research and development of novel biologic gene therapies to treat Parkinson's disease and other neurodegenerative diseases. The company was founded by Asa Abeliovich on July 6, 2017 and is headquartered in New York, NY. | Health Technology |
Vitae Pharmaceuticals LLC
 Vitae Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vitae Pharmaceuticals LLC is a clinical-stage bio-pharmaceutical company, which engages in discovering and developing novel, small molecule drugs for diseases, including chronic kidney disease, diabetes and Alzheimer's disease, and autoimmune disorders, acute coronary syndrome, and immuno-oncology. The company was founded by John J. Baldwin, Bartosz A. Grzybowski, George M. Whitesides, and Eugene Shakhnovich on May 21, 2001 and is headquartered in Fort Washington, PA. | Health Technology |
Allergan GI Corp.
Allergan GI Corp. BiotechnologyHealth Technology Allergan GI Corp. develops peptide therapeutics for the treatment of gastrointestinal disorders. It provides RM-493 a small-peptide melanocortin-4 receptor agonist, for the treatment of obesity and diabetes, and RM-131 a small-peptide ghrelin agonist, for the treatment of diabetic gastro paresis and other gastrointestinal functional disorders. The company was founded by Bart Henderson and Elizabeth Stoner in 2008 and is headquartered in Madison, NJ. | Health Technology |
Tobira Therapeutics, Inc.
 Tobira Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tobira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The company was founded on September 11, 2006 and is headquartered in Madison, NJ. | Health Technology |
